Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ProSavin is safe and improves motor scores in Parkinson's disease

June 15, 2010

R-7160 evaluated in phase I/II trial in solid tumors

June 15, 2010

CSPG4 may represent prognostic biomarker for chordoma

June 15, 2010

Armodafinil evaluated in healthy subjects and in patients with excessive sleepiness

June 15, 2010

MGMTP140K-modified CD34+ stem cells efficiently engrafted into patients with glioblastoma

June 15, 2010

Cediranib to enter phase II trial in advanced biliary tract cancers

June 14, 2010

ANR-94 is active in rodent models of Parkinson's disease

June 14, 2010

Trials suggest dasatinib or nilotinib could replace imatinib as first-line CML therapy

June 14, 2010

MRX-4 improves several symptoms of grass pollen allergy

June 14, 2010

Dystrophin-based gene therapy evaluated in Duchenne's muscular dystrophy

June 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...